Hypophosphatemia after intravenous iron therapy: Comprehensive review of clinical findings and recommendations for management.
Schaefer B, Tobiasch M, Wagner S, Glodny B, Tilg H, Wolf M, Zoller H.
Bone. 2022 Jan;154:116202. doi: 10.1016/j.bone.2021.116202. Epub 2021 Sep 15.
Neurologic conditions and disorders of uremic syndrome of chronic kidney disease: presentations, causes, and treatment strategies.
Hamed SA.
Expert Rev Clin Pharmacol. 2019 Jan;12(1):61-90. doi: 10.1080/17512433.2019.1555468. Epub 2019 Jan 11.
Parathyroid disease.
Wen HY, Schumacher HR Jr, Zhang LY.
Rheum Dis Clin North Am. 2010 Nov;36(4):647-64. doi: 10.1016/j.rdc.2010.09.002.
Endocrine myopathies.
Ruff RL, Weissmann J.
Neurol Clin. 1988 Aug;6(3):575-92.
Primary hyperparathyroidism.
Bilezikian JP, Cusano NE, Khan AA, Liu JM, Marcocci C, Bandeira F.
Nat Rev Dis Primers. 2016 May 19;2:16033. doi: 10.1038/nrdp.2016.33.
[Primary hyperparathyroidism].
Maruani G, Cornière N, Nicolet L, Baron S, Courbebaisse M, Renaud S, Houillier P.
Rev Med Interne. 2013 Oct;34(10):605-13. doi: 10.1016/j.revmed.2012.10.369. Epub 2012 Nov 26.
Endocrine myopathies.
Kendall-Taylor P, Turnbull DM.
Br Med J (Clin Res Ed). 1983 Sep 10;287(6394):705-8. doi: 10.1136/bmj.287.6394.705.
Ischemic myopathy in uremic hyperparathyroidism.
Goodhue WW, Davis JN, Porro RS.
JAMA. 1972 Aug 21;221(8):911-2.
Normocalcemic Primary Hyperparathyroidism Presenting with Muscle Weakness and Body Pain.
Mihashi I, Ishii K, Ogawa Y, Uchida A, Hara H, Tamaoka A.
Intern Med. 2021 Mar 15;60(6):953-956. doi: 10.2169/internalmedicine.6131-20. Epub 2020 Nov 30.
Hyperparathyroidism-related extensor tenosynovitis at the wrist: a general review of the literature.
Ichihara S, Hidalgo-Diaz JJ, Prunières G, Facca S, Bodin F, Boucher S, Liverneaux P.
Eur J Orthop Surg Traumatol. 2015 Jul;25(5):793-7. doi: 10.1007/s00590-015-1596-3. Epub 2015 Jan 31.
